ARCHIVES

First-Line Bendamustine Doubles PFS In Non-Hodgkin and Mantle Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

AC To Refuse Government Help In Future Projects

November 24, 1978

Votrient Trial Meets PFS Endpoint In Epithelial Ovarian Cancer

June 28, 2013

In Multi-Site Phase I Studies, No Investigator Sees All Toxicities

March 26, 2010

Conversation with TCL:Demetri: Morcellation Worsens Outcomes In Patients with Undiagnosed Cancers

November 21, 2014

ADT May Increase Risk Of Cardio Events In Prostate Cancer Patients

February 5, 2010

States Join Suit Alleging Amgen Offered Illegal Kickback To Doctors For Aranesp

November 6, 2009